Home Nucleus Biotechnology U.S. Circulating Tumor Cells (CTC) Liquid Biopsy Market to 2032

U.S. Circulating Tumor Cells (CTC) Liquid Biopsy Market to 2032

Overview

The U.S. Circulating Tumor Cells (CTC) Liquid Biopsy Market is expected to reach a 4,510.01 USD Million by 2032 and is projected to grow at a CAGR of 41.18% from 2025 to 2032.

Revenue, 2024 (USD Million)
727.11
Forecast, 2032 (USD Million)
4,510.01
CAGR, 2024 - 2032
41.18%
Report Coverage
U.S.

U.S. Circulating Tumor Cells (CTC) Liquid Biopsy Market 2018-2032 USD Million

U.S. Circulating Tumor Cells (CTC) Liquid Biopsy Market, Key Findings (2025-2032)

Market Growth and Projections:

  • Market Size (2024): 727.11 USD Million
  • Projected Market Size (2032): 4,510.01 USD Million
  • CAGR (2025-2032): 41.18%

Key Findings of U.S. Circulating Tumor Cells (CTC) Liquid Biopsy Market

  • The U.S. Circulating Tumor Cells (CTC) Liquid Biopsy Market was valued at 727.11 USD Million in 2024.
  • The U.S. Circulating Tumor Cells (CTC) Liquid Biopsy Market is likely to grow at a CAGR of 41.18% during the forecast period of 2024 to 2032.
  • In 2024, the Largest segment Research & Academic Institutes in End User Segment accounted for the largest share of the market with a revenue of 636.63 USD Million
  • The fastest growing segment CTC Detection Methods in Technology Segment grew Fastest with a CAGR of 51.29% during the forecast period from 2024 to 2032.

U.S. Circulating Tumor Cells (CTC) Liquid Biopsy Market Scope

U.S. Circulating Tumor Cells (CTC) Liquid Biopsy Market Segmentation & Scope
Technology
  • Immunocytochemical Technologies
  • Negative Selection
  • Single Spiral Microchannel
  • Microchips
  • Xenotransplantation Models
  • Functional In vitro Cell Invasion Assay
  • Molecular (RNA)-Based Technologies
  • Ex Vivo Positive Selection
  • CTC Enrichment Methods
  • CTC Detection Methods
Application
  • Multiple Chromosome Abnormalities
  • Cancer Stem Cell Research
  • Others
End User
  • Physician Laboratories
  • Hospitals
  • Reference Laboratories
  • Research & Academic Institutes

U.S. Circulating Tumor Cells (CTC) Liquid Biopsy Market Data Coverage Insights

Study Period 2024-2032
Base Year 2020
Unit Revenue in USD Million
Market Value in 2024 727.11 USD Million
Market Value in 2032 4,510.01 USD Million
CAGR (2025-2032) 41.18%
Historic Data 2016-2023
Market Segments Covered Technology,Application,End User

Regional Insights:

  • Leading Market (2024-2032): U.S., leading in terms of revenue 727.11 USD Million in 2024
    • Key Country: U.S., leading in terms of revenue with value of 727.11 USD Million in 2024.

Segments and Scope

  • U.S. Circulating Tumor Cells (CTC) Liquid Biopsy Market to 2032, By Technology
    • CTC Detection Methods is the largest segment in U.S. Circulating Tumor Cells (CTC) Liquid Biopsy Market to 2032 with a revenue of 175.09 USD Million in the year 2024.
    • CTC Detection Methods is the Fastest growing segment in U.S. Circulating Tumor Cells (CTC) Liquid Biopsy Market to 2032 with a Growth rate of 51.29 % in forecast period 2025-2032.
  • U.S. Circulating Tumor Cells (CTC) Liquid Biopsy Market to 2032, By Application
    • Cancer Stem Cell Research is the largest segment in U.S. Circulating Tumor Cells (CTC) Liquid Biopsy Market to 2032 with a revenue of 244.84 USD Million in the year 2024.
    • Cancer Stem Cell Research is the Fastest growing segment in U.S. Circulating Tumor Cells (CTC) Liquid Biopsy Market to 2032 with a Growth rate of 46.89 % in forecast period 2025-2032.
  • U.S. Circulating Tumor Cells (CTC) Liquid Biopsy Market to 2032, By End User
    • Research & Academic Institutes is the largest segment in U.S. Circulating Tumor Cells (CTC) Liquid Biopsy Market to 2032 with a revenue of 636.63 USD Million in the year 2024.
    • Research & Academic Institutes is the Fastest growing segment in U.S. Circulating Tumor Cells (CTC) Liquid Biopsy Market to 2032 with a Growth rate of 41.67 % in forecast period 2025-2032.

U.S. Circulating Tumor Cells (CTC) Liquid Biopsy Market Company Share Analysis

 
Company Name Company Share Analysis
Myriad Genetics, Inc.
Natera, Inc.
Illumina, Inc.
Immucor
Thermo Fisher Scientific Inc.
U.S. Circulating Tumor Cells (CTC) Liquid Biopsy Market Company Share Analysis

U.S. Circulating Tumor Cells (CTC) Liquid Biopsy Market Geographical Sales Distribution, 2018-2032 USD Million

U.S. Circulating Tumor Cells (CTC) Liquid Biopsy Market Geographical Sales Distribution, 2018-2032 USD Million

U.S. Circulating Tumor Cells (CTC) Liquid Biopsy Market Company Profiling

U.S. Circulating Tumor Cells (CTC) Liquid Biopsy Market Company Profiling

Industry Related Reports

South America Cell And Gene Therapy Thawing Equipment Market
Middle East & Africa Cell And Gene Therapy Thawing Equipment Market
North America Cell And Gene Therapy Thawing Equipment Market
Europe Cell And Gene Therapy Thawing Equipment Market
Asia-Pacific Cell And Gene Therapy Thawing Equipment Market
Argentina Cell And Gene Therapy Thawing Equipment Market
Australia Cell And Gene Therapy Thawing Equipment Market
Belgium Cell And Gene Therapy Thawing Equipment Market
Brazil Cell And Gene Therapy Thawing Equipment Market
Canada Cell And Gene Therapy Thawing Equipment Market
Frequently Asked Questions
The U.S. Circulating Tumor Cells (CTC) Liquid Biopsy Market is segmented based on Segmentation Technology,Application,End User.
U.S. Circulating Tumor Cells (CTC) Liquid Biopsy Market was valued at USD 727.11(Revenue in USD Million) in 2020.
U.S. Circulating Tumor Cells (CTC) Liquid Biopsy Market is projected to grow at a CAGR of 41.18% during the forecast period of 2024 to 2032.
The Research & Academic Institutes segment is expected to dominate the U.S. Circulating Tumor Cells (CTC) Liquid Biopsy Market, holding a largest market share of 636.63 USD Million in 2024

Coming Soon....

U.S. Circulating Tumor Cells (CTC) Liquid Biopsy Market Scope

U.S. Circulating Tumor Cells (CTC) Liquid Biopsy Market Segmentation & Scope
Technology
  • Immunocytochemical Technologies
  • Negative Selection
  • Single Spiral Microchannel
  • Microchips
  • Xenotransplantation Models
  • Functional In vitro Cell Invasion Assay
  • Molecular (RNA)-Based Technologies
  • Ex Vivo Positive Selection
  • CTC Enrichment Methods
  • CTC Detection Methods
Application
  • Multiple Chromosome Abnormalities
  • Cancer Stem Cell Research
  • Others
End User
  • Physician Laboratories
  • Hospitals
  • Reference Laboratories
  • Research & Academic Institutes
Frequently Asked Questions
The U.S. Circulating Tumor Cells (CTC) Liquid Biopsy Market is segmented based on Segmentation Technology,Application,End User.
U.S. Circulating Tumor Cells (CTC) Liquid Biopsy Market was valued at USD 727.11(Revenue in USD Million) in 2020.
U.S. Circulating Tumor Cells (CTC) Liquid Biopsy Market is projected to grow at a CAGR of 41.18% during the forecast period of 2024 to 2032.
The estimated market value of the U.S. Circulating Tumor Cells (CTC) Liquid Biopsy Market for final year is USD 4,510.01 (USD Million).

U.S. Circulating Tumor Cells (CTC) Liquid Biopsy Market Company Profiling

U.S. Circulating Tumor Cells (CTC) Liquid Biopsy Market Company Profiling
Frequently Asked Questions
The U.S. Circulating Tumor Cells (CTC) Liquid Biopsy Market is segmented based on Segmentation Technology,Application,End User.
U.S. Circulating Tumor Cells (CTC) Liquid Biopsy Market was valued at USD 727.11(Revenue in USD Million) in 2020.
U.S. Circulating Tumor Cells (CTC) Liquid Biopsy Market is projected to grow at a CAGR of 41.18% during the forecast period of 2024 to 2032.
The estimated market value of the U.S. Circulating Tumor Cells (CTC) Liquid Biopsy Market for final year is USD 4,510.01 (USD Million).

Related Markets

HAVE A QUESTION?

Get expert advice on the right strategy for your business at no cost. We also offer customized subscription plans and affordable discounts for startups and universities.